BIOFRONTERA AG NA ON KONV
BIOFRONTERA AG NA ON KONV/ DE000A4BGGM7 /
B8FK
|
29/05/2024 08:01:17
|
Chg.
-0.1495
|
Volume |
Bid10:30:00 |
Ask10:30:00 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
3.5205EUR
|
-4.07%
|
0
Turnover: 0.0000 |
3.5205Bid Size: 100 |
3.7700Ask Size: 100 |
10.63 mill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-0.21 EUR |
-98.70% |
| EPS Diluted: |
- EUR |
-98.70% |
| Revenues per Share: |
10.61 EUR |
25.30% |
| Book Value per Share: |
6.58 EUR |
-1.75% |
| Cash Flow per Share: |
-0.63 EUR |
-51.09% |
| Dividend per Share: |
- EUR |
- |
| Total |
in mill. |
|
| Revenues: |
32.25 EUR |
25.30% |
| Net Income: |
-0.37 EUR |
-99.16% |
| Operating Cash Flow: |
-1.91 EUR |
- |
| Cash and Cash Equivalents: |
3.08 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
0.33 |
0.79 |
| P/BV ratio: |
0.53 |
1.28 |
| P/CF Ratio: |
-5.58 |
-13.43 |
| PEG: |
0.17 |
- |
| Earnings Yield: |
-6.00% |
-2.49% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
10.63 mill. EUR |
25.59 mill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
- EUR |
- EUR |
| Shares Outstanding: |
3.04 mill. |
|
Profitability
| Gross Profit Margin: |
80.64% |
| EBIT Margin: |
15.91% |
| Net Profit Margin: |
-1.14% |
| Return on Equity: |
-1.85% |
| Return on Assets: |
-1.20% |
Financial Strength
| Liquidity I / Cash Ratio: |
30.58% |
| Liquidity II / Quick Ratio: |
38.26% |
| Liquidity III / Current Ratio: |
175.92% |
| Debt / Equity Ratio: |
53.81% |
| Dynam. Debt / Equity Ratio: |
-564.41% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- EUR |
| Revenues / Employee: |
- EUR |
| Net Income / Employee: |
- EUR |
| Total Assets / Employee: |
- EUR |
| * Fiscal Year End: |
31/12/2023 |
| Accounting Standard: |
IFRS |
